CombinatoRx, the Cambridge, MA-based biotech company, is cutting 30 more jobs, which means it has now eliminated two-thirds of its staff since its lead drug candidate for arthritis failed in a clinical trial in early October.
The company will be left with 55 employees.
Source: Xconomy
Saturday, November 22, 2008
Subscribe to:
Post Comments (Atom)
Related Posts
0 comments:
Post a Comment